ATOMOXETINE

ATOMOXETINE was reported 23875 times

ATOMOXETINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BODY STALK ANOMALY 3 0.6000
1 GROWTH HORMONE-PRODUCING PITUITARY TUMOUR 12 0.3750
2 PUNCTURE SITE INFLAMMATION 3 0.1364
3 SPONTANEOUS EJACULATION 7 0.1111
4 DECREASED EYE CONTACT 28 0.0921
5 FACET JOINT SYNDROME 281 0.0862
6 CONTRACEPTION 2 0.0741
7 OPPOSITIONAL DEFIANT DISORDER 28 0.0709
8 PERIPHERAL VENOUS DISEASE 286 0.0700
9 ONYCHOMADESIS 286 0.0681
10 HEPATIC ENZYME 9 0.0604
11 MANIC SYMPTOM 10 0.0595
12 PUNCTURE SITE BRUISE 3 0.0588
13 OVERLAP SYNDROME 39 0.0557
14 BLEPHAROSPASM 341 0.0541
15 ACQUIRED PLAGIOCEPHALY 2 0.0541
16 HYPOCHOLESTEROLAEMIA 19 0.0538
17 RHEUMATIC FEVER 238 0.0533
18 UMBILICAL CORD SHORT 3 0.0526
19 CONGENITAL ABSENCE OF CRANIAL VAULT 3 0.0517
20 CARDIAC VALVE THICKENING 3 0.0508
21 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 352 0.0491
22 CONGESTIVE HEPATOPATHY 20 0.0446
23 BREAST CANCER STAGE III 282 0.0435
24 SHUNT MALFUNCTION 12 0.0424
25 ONYCHOMYCOSIS 186 0.0423
26 GASTRIC HYPOMOTILITY 12 0.0391
27 PRODUCT LABEL CONFUSION 226 0.0387
28 NAIL DISORDER 336 0.0384
29 MALE GENITAL ATROPHY 4 0.0374
30 DUODENAL ULCER PERFORATION 276 0.0371
31 INFUSION SITE REACTION 105 0.0351
32 VIRAL DIARRHOEA 12 0.0349
33 VASCULAR ACCESS SITE EXTRAVASATION 3 0.0345
34 LIVE BIRTH 282 0.0337
35 FINGER DEFORMITY 162 0.0334
36 ONYCHOPHAGIA 9 0.0326
37 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 18 0.0321
38 GRIP STRENGTH DECREASED 277 0.0314
39 MUSCLE INJURY 257 0.0310
40 CHOREOATHETOSIS 21 0.0309
41 HELICOBACTER INFECTION 313 0.0304
42 HYPERCHOLESTEROLAEMIA 292 0.0302
43 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 3 0.0286
44 FOLLICULITIS 299 0.0285
45 C-REACTIVE PROTEIN ABNORMAL 180 0.0280
46 LIP DRY 253 0.0278
47 DEEP VEIN THROMBOSIS POSTOPERATIVE 53 0.0265
48 SUPINE HYPERTENSION 5 0.0265
49 HAND DEFORMITY 346 0.0264
50 COELIAC DISEASE 255 0.0260
51 LUPUS VULGARIS 32 0.0254
52 ADULTERATED PRODUCT 5 0.0250
53 PEMPHIGUS 310 0.0248
54 BURSITIS 300 0.0247
55 BACK INJURY 264 0.0243
56 WOUND INFECTION 261 0.0238
57 SHUNT OCCLUSION 12 0.0236
58 X-RAY ABNORMAL 42 0.0235
59 EOSINOPENIA 3 0.0227
60 PICA 4 0.0222
61 PAINFUL EJACULATION 5 0.0221
62 BLOOD GROWTH HORMONE INCREASED 12 0.0215
63 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 43 0.0207
64 C-REACTIVE PROTEIN 19 0.0205
65 COMPULSIVE LIP BITING 2 0.0192
66 DISLOCATION OF VERTEBRA 43 0.0188
67 REBOUND PSYCHOSIS 4 0.0188
68 CYCLOTHYMIC DISORDER 3 0.0183
69 JOINT RANGE OF MOTION DECREASED 242 0.0180
70 PERICARDITIS 292 0.0174
71 OBESITY 270 0.0169
72 GRANDIOSITY 6 0.0164
73 OBSESSIVE-COMPULSIVE SYMPTOM 6 0.0163
74 SYNOVITIS 292 0.0162
75 GLOSSODYNIA 359 0.0160
76 SWOLLEN JOINT COUNT 4 0.0160
77 ADVERSE REACTION 210 0.0158
78 CONGENITAL ANOMALY 121 0.0156
79 TASTE DISORDER 314 0.0155
80 SWOLLEN JOINT COUNT INCREASED 47 0.0147
81 NORMAL NEWBORN 80 0.0147
82 LYMPHOCYTIC HYPOPHYSITIS 4 0.0145
83 PENILE DISCHARGE 4 0.0143
84 IRRITABLE BOWEL SYNDROME 293 0.0137
85 GRIP STRENGTH 3 0.0131
86 PUNCTURE SITE PAIN 3 0.0129
87 DELUSION OF PARASITOSIS 2 0.0127
88 ENCEPHALOCELE 3 0.0120
89 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 8 0.0120
90 LIVER INJURY 294 0.0120
91 PORPHYRIA ACUTE 17 0.0118
92 FIBROMYALGIA 288 0.0118
93 KYPHOSCOLIOSIS 3 0.0114
94 LIVER FUNCTION TEST INCREASED 243 0.0113
95 EPILEPSY 344 0.0112
96 INTESTINAL CYST 3 0.0111
97 ADMINISTRATION SITE DISCOMFORT 2 0.0106
98 PATIENT UNCOOPERATIVE 5 0.0105
99 HYPERKINESIA 22 0.0104
100 BONE EROSION 36 0.0102
101 DERMATILLOMANIA 6 0.0101
102 ADRENOMEGALY 2 0.0096
103 WOUND 266 0.0095
104 CONTRAINDICATED PRODUCT ADMINISTERED 277 0.0091
105 DRUG-INDUCED LIVER INJURY 279 0.0089
106 DYSPRAXIA 5 0.0089
107 GAIT INABILITY 294 0.0088
108 RETINITIS 15 0.0087
109 ACTIVATION SYNDROME 3 0.0087
110 TYPE 2 DIABETES MELLITUS 292 0.0087
111 IMPAIRED HEALING 277 0.0084
112 INSULIN-LIKE GROWTH FACTOR INCREASED 12 0.0084
113 SYSTEMIC LUPUS ERYTHEMATOSUS 290 0.0082
114 NIGHT SWEATS 263 0.0082
115 SINGLE UMBILICAL ARTERY 3 0.0081
116 RHEUMATOID FACTOR POSITIVE 46 0.0080
117 C-REACTIVE PROTEIN INCREASED 283 0.0078
118 CONGENITAL HYPOTHYROIDISM 2 0.0078
119 BLOOD CHOLESTEROL INCREASED 354 0.0076
120 PSORIATIC ARTHROPATHY 308 0.0076
121 OCULOGYRIC CRISIS 16 0.0074
122 AUTOSCOPY 4 0.0074
123 SCROTAL PAIN 4 0.0074
124 HOMICIDAL IDEATION 30 0.0074
125 TIC 40 0.0073
126 COOMBS TEST POSITIVE 2 0.0073
127 HEPATITIS 187 0.0073
128 NAIL OPERATION 3 0.0072
129 BULBAR PALSY 2 0.0072
130 GROSS MOTOR DELAY 2 0.0070
131 SERONEGATIVE ARTHRITIS 8 0.0070
132 ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 0.0069
133 OSTEOARTHRITIS 291 0.0069
134 BLUNTED AFFECT 5 0.0068
135 COLD-STIMULUS HEADACHE 2 0.0063
136 ARTHROPATHY 346 0.0062
137 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 12 0.0061
138 FLIGHT OF IDEAS 3 0.0058
139 LOWER RESPIRATORY TRACT INFECTION 261 0.0057
140 INFLAMMATION 295 0.0057
141 EXOMPHALOS 3 0.0056
142 SOMATIC SYMPTOM DISORDER 6 0.0056
143 HEPATIC ENZYME INCREASED 378 0.0055
144 NEUROGENIC SHOCK 3 0.0055
145 AUTOIMMUNE DISORDER 54 0.0055
146 PUSTULAR PSORIASIS 19 0.0055
147 OROMANDIBULAR DYSTONIA 4 0.0055
148 URINARY HESITATION 13 0.0054
149 BRUXISM 29 0.0054
150 LUNG DISORDER 263 0.0054
151 ECZEMA EYELIDS 3 0.0054
152 DISTRACTIBILITY 6 0.0052
153 THERAPEUTIC PRODUCT EFFECT DECREASED 231 0.0052
154 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 17 0.0051
155 IMPULSIVE BEHAVIOUR 19 0.0051
156 BLISTER 282 0.0050
157 BREATH ODOUR 12 0.0049
158 INFREQUENT BOWEL MOVEMENTS 12 0.0048
159 STRABISMUS 14 0.0048
160 SUSPECTED SUICIDE 22 0.0047
161 NECK PAIN 261 0.0047
162 INFUSION RELATED REACTION 309 0.0047
163 DRUG TOLERANCE DECREASED 13 0.0046
164 MYOCARDITIS 53 0.0046
165 PRESSURE OF SPEECH 3 0.0046
166 HEAT STROKE 7 0.0046
167 CLAUSTROPHOBIA 5 0.0046
168 TREATMENT FAILURE 380 0.0046
169 RENAL TUBULAR ACIDOSIS 10 0.0046
170 ULCER HAEMORRHAGE 31 0.0046
171 RUBBER SENSITIVITY 7 0.0046
172 SOCIAL ANXIETY DISORDER 3 0.0046
173 EXPOSURE DURING PREGNANCY 283 0.0045
174 FEELING GUILTY 6 0.0045
175 STOMATITIS 274 0.0045
176 MUSCULOSKELETAL PAIN 234 0.0045
177 HEPATIC ENZYME DECREASED 2 0.0045
178 IMPULSE-CONTROL DISORDER 9 0.0044
179 DRUG INTOLERANCE 422 0.0044
180 TONGUE BITING 9 0.0044
181 EJACULATION DISORDER 12 0.0042
182 WHEEZING 249 0.0042
183 MATERNAL EXPOSURE DURING PREGNANCY 374 0.0042
184 GASTROOESOPHAGEAL REFLUX DISEASE 337 0.0042
185 SLEEP DISORDER 291 0.0041
186 BREAST CANCER STAGE II 34 0.0041
187 HYPOMANIA 15 0.0041
188 EMOTIONAL POVERTY 7 0.0040
189 BRUGADA SYNDROME 4 0.0039
190 MOBILITY DECREASED 277 0.0039
191 GRIMACING 3 0.0038
192 AUTISM SPECTRUM DISORDER 21 0.0038
193 DRY MOUTH 307 0.0038
194 TORTICOLLIS 8 0.0038
195 ANTICHOLINERGIC SYNDROME 6 0.0038
196 BINGE EATING 4 0.0037
197 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 24 0.0037
198 EXECUTIVE DYSFUNCTION 2 0.0037
199 TRISMUS 19 0.0037
200 EFFUSION 5 0.0037
201 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
202 EXOSTOSIS 33 0.0036
203 INJURY 254 0.0036
204 STREPTOCOCCAL INFECTION 20 0.0036
205 GASTROINTESTINAL DISORDER 319 0.0036
206 RASH VESICULAR 17 0.0035
207 HEAD BANGING 2 0.0035
208 FLASHBACK 2 0.0035
209 HYPERREFLEXIA 12 0.0034
210 HEPATIC ENCEPHALOPATHY 32 0.0034
211 PRODUCT TAMPERING 6 0.0033
212 DEEP BRAIN STIMULATION 2 0.0033
213 CLUMSINESS 9 0.0033
214 HYPERSEXUALITY 6 0.0033
215 DISTURBANCE IN SEXUAL AROUSAL 3 0.0033
216 PARADOXICAL DRUG REACTION 12 0.0033
217 VENOUS INJURY 3 0.0032
218 GENERAL PHYSICAL HEALTH DETERIORATION 369 0.0032
219 RED BLOOD CELL SEDIMENTATION RATE INCREASED 35 0.0032
220 DRUG TOLERANCE 16 0.0032
221 INTENTIONAL PRODUCT USE ISSUE 273 0.0031
222 MUSCULOSKELETAL STIFFNESS 273 0.0031
223 DYSPEPSIA 298 0.0030
224 SWELLING 282 0.0030
225 EDUCATIONAL PROBLEM 5 0.0030
226 HALLUCINATION, TACTILE 2 0.0030
227 MIGRAINE 282 0.0030
228 PRESCRIBED OVERDOSE 57 0.0029
229 JOINT SWELLING 351 0.0029
230 INFUSION SITE DISCOMFORT 3 0.0029
231 DROOLING 20 0.0029
232 ILL-DEFINED DISORDER 175 0.0029
233 SLEEP DEFICIT 6 0.0028
234 FOOD INTERACTION 5 0.0028
235 EYE MOVEMENT DISORDER 19 0.0028
236 OBSESSIVE THOUGHTS 5 0.0028
237 PILOERECTION 3 0.0027
238 FACIAL SPASM 3 0.0027
239 LUPUS-LIKE SYNDROME 24 0.0026
240 SUICIDAL BEHAVIOUR 11 0.0026
241 DYSTONIA 51 0.0026
242 INJECTION SITE REACTION 179 0.0026
243 MEAN CELL VOLUME DECREASED 4 0.0026
244 WALKING AID USER 17 0.0026
245 HYPOAESTHESIA 381 0.0025
246 RHEUMATOID ARTHRITIS 289 0.0025
247 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 179 0.0025
248 ABDOMINAL DISTENSION 262 0.0025
249 COORDINATION ABNORMAL 35 0.0025
250 LOWER LIMB FRACTURE 48 0.0025
251 OBSESSIVE-COMPULSIVE DISORDER 20 0.0025
252 PULSE ABNORMAL 6 0.0025
253 STRESS CARDIOMYOPATHY 14 0.0024
254 NASAL PRURITUS 3 0.0024
255 MATERNAL EXPOSURE TIMING UNSPECIFIED 9 0.0024
256 SCIATICA 38 0.0024
257 MEMORY IMPAIRMENT 326 0.0024
258 RENAL TUBULAR NECROSIS 23 0.0023
259 AGGRESSION 117 0.0023
260 INFUSION SITE IRRITATION 3 0.0023
261 DEREALISATION 5 0.0023
262 PUPIL FIXED 4 0.0023
263 PRESCRIBED UNDERDOSE 46 0.0023
264 EYE INJURY 7 0.0023
265 PERSONALITY DISORDER 6 0.0023
266 CATATONIA 12 0.0023
267 CATHETER SITE PRURITUS 2 0.0023
268 ABDOMINAL DISCOMFORT 382 0.0023
269 PARAESTHESIA 358 0.0023
270 COMPLETED SUICIDE 187 0.0022
271 PULMONARY FIBROSIS 43 0.0022
272 HYPERPLASIA 2 0.0022
273 TESTICULAR PAIN 7 0.0022
274 AFFECT LABILITY 21 0.0022
275 INTENTIONAL SELF-INJURY 44 0.0022
276 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 5 0.0022
277 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
278 CONFUSIONAL STATE 350 0.0022
279 FOOT DEFORMITY 24 0.0022
280 MUSCULAR WEAKNESS 242 0.0021
281 HEPATIC CONGESTION 2 0.0021
282 PUSTULE 5 0.0021
283 EOSINOPHIL COUNT DECREASED 5 0.0021
284 NEUROLOGICAL SYMPTOM 12 0.0021
285 DISSOCIATION 16 0.0021
286 SEROTONIN SYNDROME 40 0.0021
287 NYSTAGMUS 11 0.0021
288 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
289 PRIAPISM 7 0.0020
290 HALLUCINATION, AUDITORY 32 0.0020
291 AORTIC STENOSIS 7 0.0020
292 BRAIN INJURY 20 0.0020
293 NIPPLE PAIN 4 0.0020
294 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 94 0.0020
295 PERIPHERAL SWELLING 301 0.0020
296 IRRITABILITY 117 0.0019
297 MANIA 32 0.0019
298 SUICIDAL IDEATION 178 0.0019
299 FULMINANT TYPE 1 DIABETES MELLITUS 2 0.0019
300 JOINT DESTRUCTION 3 0.0019
301 HYPERTENSION 408 0.0019
302 SPONDYLITIS 7 0.0019
303 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
304 EAR PAIN 37 0.0019
305 PRODUCT QUALITY ISSUE 257 0.0019
306 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 32 0.0019
307 ALOPECIA 368 0.0019
308 TEARFULNESS 8 0.0019
309 HEPATIC NECROSIS 7 0.0019
310 ABDOMINAL PAIN UPPER 380 0.0018
311 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
312 ENCEPHALOPATHY 45 0.0018
313 BIPOLAR I DISORDER 4 0.0018
314 ILLUSION 3 0.0018
315 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 31 0.0018
316 INTRACRANIAL PRESSURE INCREASED 10 0.0018
317 CLEFT LIP AND PALATE 2 0.0018
318 CRYING 65 0.0018
319 DELIRIUM 61 0.0018
320 CHOREA 3 0.0017
321 CHEMICAL BURN 2 0.0017
322 GENERAL SYMPTOM 13 0.0017
323 FACE OEDEMA 29 0.0017
324 GAMBLING 2 0.0017
325 GALACTORRHOEA 11 0.0017
326 BREAST DISCHARGE 3 0.0017
327 DEPRESSION 386 0.0017
328 URTICARIA 282 0.0017
329 ATRIOVENTRICULAR BLOCK 13 0.0017
330 URINE FLOW DECREASED 4 0.0017
331 MYOSITIS 15 0.0017
332 METABOLIC ENCEPHALOPATHY 5 0.0017
333 BRONCHIAL HYPERREACTIVITY 2 0.0017
334 SELF ESTEEM DECREASED 4 0.0017
335 ABNORMAL LOSS OF WEIGHT 11 0.0016
336 IMPATIENCE 3 0.0016
337 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
338 HYPERSENSITIVITY 293 0.0016
339 SEDATION COMPLICATION 4 0.0016
340 BLOOD BILIRUBIN ABNORMAL 2 0.0016
341 URINARY TRACT DISORDER 7 0.0016
342 ALCOHOL INTERACTION 3 0.0015
343 HYPERPROLACTINAEMIA 10 0.0015
344 POSTURE ABNORMAL 5 0.0015
345 INSOMNIA 408 0.0015
346 NASOPHARYNGITIS 282 0.0015
347 PSYCHOTIC DISORDER 45 0.0015
348 DISCOMFORT 92 0.0015
349 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
350 SALIVARY HYPERSECRETION 15 0.0015
351 EJACULATION FAILURE 3 0.0015
352 HEPATIC CIRRHOSIS 28 0.0015
353 MUSCLE SPASMS 270 0.0015
354 AGITATION 107 0.0015
355 WEIGHT INCREASED 322 0.0014
356 WALKING DISABILITY 3 0.0014
357 SELF-INJURIOUS IDEATION 6 0.0014
358 ELECTRIC SHOCK SENSATION 4 0.0014
359 JOINT DISLOCATION 15 0.0014
360 DEPRESSIVE SYMPTOM 5 0.0014
361 CONDITION AGGRAVATED 431 0.0014
362 FANCONI SYNDROME 2 0.0014
363 CARDIAC FLUTTER 9 0.0014
364 DEPRESSED MOOD 72 0.0014
365 GENITAL PAIN 2 0.0014
366 EXCESSIVE EYE BLINKING 2 0.0014
367 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
368 FOETAL EXPOSURE DURING PREGNANCY 108 0.0013
369 ACNE CYSTIC 4 0.0013
370 HEPATIC FAILURE 40 0.0013
371 CARDIO-RESPIRATORY ARREST 55 0.0013
372 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
373 PRODUCT USE IN UNAPPROVED INDICATION 325 0.0013
374 IMMUNE THROMBOCYTOPENIA 6 0.0013
375 GASTROSTOMY 2 0.0013
376 FEELING OF DESPAIR 6 0.0013
377 THERAPY PARTIAL RESPONDER 20 0.0013
378 BRAIN FOG 20 0.0013
379 EUPHORIC MOOD 13 0.0013
380 SCREAMING 8 0.0013
381 POOR QUALITY SLEEP 27 0.0013
382 INTENTIONAL OVERDOSE 80 0.0012
383 FRUSTRATION TOLERANCE DECREASED 10 0.0012
384 PRODUCT USE ISSUE 232 0.0012
385 SPINAL FUSION SURGERY 5 0.0012
386 ACUTE PSYCHOSIS 3 0.0012
387 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
388 BLOOD CALCIUM ABNORMAL 2 0.0012
389 HYPERAMMONAEMIA 6 0.0012
390 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
391 ASPIRATION 13 0.0012
392 DYSPHORIA 6 0.0012
393 GAZE PALSY 2 0.0012
394 MOOD ALTERED 32 0.0012
395 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
396 PERICARDIAL EFFUSION 27 0.0012
397 PERIPHERAL VASCULAR DISORDER 6 0.0012
398 THERAPY NON-RESPONDER 52 0.0012
399 CATHETER SITE PAIN 3 0.0012
400 ELECTROCARDIOGRAM QT PROLONGED 41 0.0011
401 HANGOVER 4 0.0011
402 PRODUCT SUBSTITUTION ISSUE 65 0.0011
403 HEAVY MENSTRUAL BLEEDING 10 0.0011
404 SEXUAL DYSFUNCTION 13 0.0011
405 INCORRECT PRODUCT ADMINISTRATION DURATION 24 0.0011
406 BIPOLAR DISORDER 12 0.0011
407 BLOOD HIV RNA INCREASED 2 0.0011
408 CLONUS 3 0.0011
409 CONTUSION 105 0.0011
410 ROAD TRAFFIC ACCIDENT 45 0.0011
411 SEDATION 28 0.0011
412 BLOOD PROLACTIN INCREASED 5 0.0011
413 WEIGHT FLUCTUATION 11 0.0011
414 DIZZINESS POSTURAL 10 0.0010
415 JOINT STIFFNESS 27 0.0010
416 CARDIAC ARREST 84 0.0010
417 OEDEMA 55 0.0010
418 MYDRIASIS 13 0.0010
419 POLYDIPSIA 4 0.0010
420 DISABILITY 20 0.0010
421 ATYPICAL PNEUMONIA 3 0.0010
422 RESPIRATORY DISORDER 30 0.0010
423 SINUS TACHYCARDIA 14 0.0010
424 PENILE PAIN 3 0.0010
425 SELF INJURIOUS BEHAVIOUR 3 0.0010
426 HIP ARTHROPLASTY 15 0.0010
427 COMPULSIVE SHOPPING 2 0.0010
428 BRAIN DEATH 3 0.0010
429 TREATMENT NONCOMPLIANCE 53 0.0010
430 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
431 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
432 THERAPEUTIC RESPONSE CHANGED 6 0.0009
433 TACHYCARDIA 84 0.0009
434 FACIAL PARALYSIS 8 0.0009
435 EXPOSURE TO TOXIC AGENT 3 0.0009
436 ARTHRALGIA 389 0.0009
437 EXOPHTHALMOS 2 0.0009
438 BEHAVIOUR DISORDER 5 0.0009
439 ANGER 31 0.0009
440 JAW DISORDER 5 0.0009
441 DYSKINESIA 37 0.0009
442 ASTHENIA 337 0.0009
443 DECREASED APPETITE 208 0.0009
444 POTENTIATING DRUG INTERACTION 3 0.0009
445 AMNESIA 58 0.0009
446 AFFECTIVE DISORDER 7 0.0009
447 SUSPECTED OFF LABEL USE 4 0.0009
448 ACUTE HEPATIC FAILURE 12 0.0009
449 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
450 VOMITING 412 0.0009
451 PAIN IN EXTREMITY 258 0.0009
452 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
453 TACHYPHRENIA 3 0.0009
454 HAEMANGIOMA 2 0.0009
455 POLYMENORRHOEA 3 0.0009
456 EAR INFECTION 23 0.0009
457 HYPERTRANSAMINASAEMIA 6 0.0009
458 BACK DISORDER 14 0.0009
459 PNEUMONIA 278 0.0009
460 EAR PRURITUS 3 0.0009
461 KNEE ARTHROPLASTY 18 0.0009
462 UNDERDOSE 62 0.0008
463 ENERGY INCREASED 5 0.0008
464 IMPAIRED QUALITY OF LIFE 12 0.0008
465 SENSATION OF FOREIGN BODY 7 0.0008
466 TOXICITY TO VARIOUS AGENTS 140 0.0008
467 THERAPY CHANGE 8 0.0008
468 LABORATORY TEST ABNORMAL 24 0.0008
469 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
470 LIVER DISORDER 36 0.0008
471 ABNORMAL WEIGHT GAIN 10 0.0008
472 HYPERTENSIVE CRISIS 9 0.0008
473 IMPAIRED GASTRIC EMPTYING 11 0.0008
474 CATHETER SITE HAEMORRHAGE 2 0.0008
475 RESPIRATORY ARREST 22 0.0008
476 STATUS EPILEPTICUS 9 0.0008
477 EXPOSURE VIA INGESTION 2 0.0008
478 FACE INJURY 3 0.0008
479 NEEDLE ISSUE 23 0.0008
480 SEIZURE 91 0.0008
481 DRUG INTERACTION 123 0.0008
482 ERUCTATION 15 0.0008
483 POOR VENOUS ACCESS 8 0.0008
484 DELUSION 12 0.0008
485 ANXIETY 216 0.0008
486 PRODUCT FORMULATION ISSUE 5 0.0008
487 RASH 329 0.0008
488 PARANOIA 13 0.0008
489 ADVERSE EVENT 69 0.0007
490 BLEPHARITIS 3 0.0007
491 DIZZINESS 373 0.0007
492 UNRESPONSIVE TO STIMULI 19 0.0007
493 OFF LABEL USE 644 0.0007
494 FEELING JITTERY 14 0.0007
495 PERIPHERAL ISCHAEMIA 3 0.0007
496 FAECALOMA 4 0.0007
497 SPEECH DISORDER 38 0.0007
498 DRUG SCREEN FALSE POSITIVE 2 0.0007
499 GASTROINTESTINAL PERFORATION 3 0.0007
500 URINARY RETENTION 24 0.0007
501 HALLUCINATIONS, MIXED 3 0.0007
502 SUICIDE ATTEMPT 43 0.0007
503 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
504 FREQUENT BOWEL MOVEMENTS 19 0.0007
505 PREGNANCY 14 0.0007
506 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
507 WITHDRAWAL SYNDROME 29 0.0007
508 ORTHOSTATIC HYPOTENSION 12 0.0007
509 DYSPHEMIA 3 0.0007
510 RESTLESSNESS 25 0.0007
511 HEADACHE 428 0.0007
512 CEREBRAL DISORDER 5 0.0007
513 URINARY INCONTINENCE 20 0.0007
514 MALAISE 296 0.0007
515 BRAIN HERNIATION 2 0.0007
516 MUSCLE RIGIDITY 8 0.0007
517 FEELING HOT 41 0.0007
518 DYSURIA 24 0.0007
519 PAIN 400 0.0007
520 EMOTIONAL DISORDER 20 0.0006
521 ASTHMA 73 0.0006
522 OXYGEN SATURATION DECREASED 36 0.0006
523 POISONING 8 0.0006
524 DISTURBANCE IN ATTENTION 34 0.0006
525 MEDICATION ERROR 35 0.0006
526 HEPATOTOXICITY 14 0.0006
527 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
528 ERECTILE DYSFUNCTION 16 0.0006
529 VULVOVAGINAL PAIN 3 0.0006
530 HALLUCINATION, VISUAL 13 0.0006
531 THIRST 11 0.0006
532 EXPIRED DEVICE USED 2 0.0006
533 ADVERSE DRUG REACTION 54 0.0006
534 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
535 BACTERIAL INFECTION 11 0.0006
536 AKATHISIA 8 0.0006
537 CORONARY ARTERY OCCLUSION 8 0.0006
538 PERIPHERAL COLDNESS 8 0.0006
539 NIGHTMARE 20 0.0006
540 NAUSEA 457 0.0006
541 OVERDOSE 124 0.0006
542 OEDEMA PERIPHERAL 69 0.0006
543 RENAL PAIN 6 0.0006
544 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
545 FATIGUE 439 0.0006
546 LEUKOPENIA 28 0.0006
547 FALL 186 0.0006
548 PRODUCT SIZE ISSUE 3 0.0006
549 TONGUE DISORDER 4 0.0006
550 APATHY 8 0.0005
551 MAJOR DEPRESSION 4 0.0005
552 HYPERKERATOSIS 3 0.0005
553 SENSITIVE SKIN 4 0.0005
554 PSYCHIATRIC SYMPTOM 4 0.0005
555 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
556 HYPERACUSIS 2 0.0005
557 OSTEOPOROSIS 22 0.0005
558 MOOD SWINGS 17 0.0005
559 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 29 0.0005
560 CIRCULATORY COLLAPSE 9 0.0005
561 NEUTROPHILIA 3 0.0005
562 SOMNOLENCE 106 0.0005
563 INSURANCE ISSUE 8 0.0005
564 COMMUNICATION DISORDER 2 0.0005
565 SINUSITIS 53 0.0005
566 HEART RATE INCREASED 51 0.0005
567 DIARRHOEA 332 0.0005
568 FAECES HARD 2 0.0005
569 DERMATITIS ATOPIC 27 0.0005
570 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
571 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
572 DRUG SCREEN POSITIVE 4 0.0005
573 DRUG INEFFECTIVE 666 0.0005
574 HYPERPHAGIA 2 0.0005
575 NERVOUSNESS 26 0.0005
576 SENSORY LOSS 4 0.0005
577 ENURESIS 2 0.0005
578 TENSION 3 0.0005
579 CHEST PAIN 91 0.0005
580 HYPERAESTHESIA 4 0.0005
581 ANAPHYLACTOID REACTION 2 0.0005
582 THINKING ABNORMAL 9 0.0005
583 ABNORMAL BEHAVIOUR 19 0.0005
584 ERECTION INCREASED 2 0.0005
585 PALLOR 13 0.0005
586 HEMIPARESIS 8 0.0005
587 HYPOPHAGIA 12 0.0005
588 INFUSION SITE PAIN 6 0.0005
589 RECTAL HAEMORRHAGE 20 0.0005
590 PLEURAL EFFUSION 28 0.0005
591 PRODUCT PREPARATION ISSUE 3 0.0005
592 AMENORRHOEA 8 0.0005
593 PULMONARY CONGESTION 6 0.0005
594 PRODUCT COMMUNICATION ISSUE 4 0.0005
595 HEAD DISCOMFORT 8 0.0005
596 RESPIRATORY RATE INCREASED 4 0.0005
597 GASTROINTESTINAL INFECTION 4 0.0004
598 CYANOSIS 7 0.0004
599 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
600 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
601 BLOOD TESTOSTERONE DECREASED 3 0.0004
602 ABDOMINAL HERNIA 2 0.0004
603 ECCHYMOSIS 3 0.0004
604 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
605 LETHARGY 25 0.0004
606 FORMICATION 3 0.0004
607 EXTRASYSTOLES 3 0.0004
608 THERAPEUTIC RESPONSE DECREASED 26 0.0004
609 COLITIS ULCERATIVE 19 0.0004
610 SEASONAL ALLERGY 6 0.0004
611 PHOTOSENSITIVITY REACTION 7 0.0004
612 CARDIAC FAILURE 34 0.0004
613 HAND FRACTURE 3 0.0004
614 GESTATIONAL DIABETES 2 0.0004
615 RECALLED PRODUCT ADMINISTERED 4 0.0004
616 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
617 ABDOMINAL PAIN 97 0.0004
618 ACUTE RESPIRATORY FAILURE 8 0.0004
619 BRADYCARDIA 22 0.0004
620 INFECTION 60 0.0004
621 FAECES SOFT 3 0.0004
622 ADRENAL INSUFFICIENCY 5 0.0004
623 WEIGHT DECREASED 115 0.0004
624 SCHIZOPHRENIA 5 0.0004
625 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
626 DYSPNOEA 232 0.0004
627 INFLAMMATORY BOWEL DISEASE 4 0.0004
628 APPLICATION SITE BURN 2 0.0004
629 DRUG WITHDRAWAL SYNDROME NEONATAL 6 0.0004
630 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
631 BREAST TENDERNESS 3 0.0004
632 PAROSMIA 3 0.0004
633 DERMATITIS ALLERGIC 5 0.0004
634 APHASIA 12 0.0004
635 PANCREATITIS 21 0.0004
636 VISION BLURRED 54 0.0004
637 HYPERTHERMIA 3 0.0004
638 BODY TEMPERATURE INCREASED 8 0.0004
639 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
640 PROCEDURAL COMPLICATION 3 0.0004
641 ATRIAL FIBRILLATION 38 0.0004
642 LEUKOCYTOSIS 7 0.0004
643 ACCIDENTAL OVERDOSE 14 0.0004
644 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
645 PRODUCT USE COMPLAINT 6 0.0004
646 FURUNCLE 3 0.0004
647 PRODUCT PRESCRIBING ERROR 9 0.0004
648 INTENTIONAL PRODUCT MISUSE 33 0.0004
649 GAIT DISTURBANCE 72 0.0004
650 MIDDLE INSOMNIA 7 0.0004
651 ANAL FISTULA 2 0.0004
652 IMPAIRED WORK ABILITY 8 0.0004
653 NEOPLASM PROGRESSION 13 0.0004
654 MIOSIS 3 0.0004
655 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
656 ANAL FISSURE 2 0.0004
657 NEURALGIA 9 0.0004
658 SKIN LACERATION 4 0.0004
659 EYE DISORDER 12 0.0004
660 DEAFNESS UNILATERAL 2 0.0004
661 MYALGIA 61 0.0004
662 HEART RATE ABNORMAL 2 0.0004
663 RASH PAPULAR 8 0.0004
664 LIMB DISCOMFORT 11 0.0004
665 SKIN REACTION 5 0.0004
666 IMPAIRED DRIVING ABILITY 4 0.0004
667 PARALYSIS 5 0.0003
668 TINNITUS 16 0.0003
669 TREMOR 57 0.0003
670 PALPITATIONS 40 0.0003
671 COLD SWEAT 6 0.0003
672 LYMPHOCYTE COUNT DECREASED 6 0.0003
673 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
674 DECREASED INTEREST 2 0.0003
675 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
676 ATAXIA 4 0.0003
677 HAEMOLYTIC ANAEMIA 3 0.0003
678 HYPERHIDROSIS 43 0.0003
679 LOSS OF LIBIDO 3 0.0003
680 BLOOD PRESSURE FLUCTUATION 8 0.0003
681 OROPHARYNGEAL DISCOMFORT 3 0.0003
682 RASH PRURITIC 18 0.0003
683 OPTIC NEURITIS 3 0.0003
684 NOCTURIA 4 0.0003
685 DISORIENTATION 13 0.0003
686 CYTOPENIA 4 0.0003
687 DRUG ABUSER 2 0.0003
688 DRUG DIVERSION 2 0.0003
689 PERSONALITY CHANGE 3 0.0003
690 CHOLANGITIS 2 0.0003
691 EXTRAPYRAMIDAL DISORDER 8 0.0003
692 RESPIRATORY TRACT CONGESTION 5 0.0003
693 FLUID RETENTION 16 0.0003
694 HYPOTENSION 63 0.0003
695 FOREIGN BODY SENSATION IN EYES 2 0.0003
696 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
697 POLLAKIURIA 13 0.0003
698 THERAPY CESSATION 16 0.0003
699 INJECTION SITE INDURATION 4 0.0003
700 VITAMIN D DEFICIENCY 3 0.0003
701 ORAL HERPES 6 0.0003
702 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
703 DYSMENORRHOEA 4 0.0003
704 POOR QUALITY DEVICE USED 3 0.0003
705 ABNORMAL DREAMS 8 0.0003
706 MENTAL IMPAIRMENT 7 0.0003
707 DEFAECATION URGENCY 2 0.0003
708 BREAST PAIN 3 0.0003
709 HEREDITARY ANGIOEDEMA 3 0.0003
710 MENSTRUATION DELAYED 3 0.0003
711 NEUTROPHIL COUNT DECREASED 11 0.0003
712 IMMUNODEFICIENCY 4 0.0003
713 MALNUTRITION 3 0.0003
714 OCULAR DISCOMFORT 3 0.0003
715 CHROMATURIA 6 0.0003
716 HEART RATE IRREGULAR 6 0.0003
717 RHABDOMYOLYSIS 11 0.0003
718 PRODUCT AVAILABILITY ISSUE 6 0.0003
719 DERMATITIS CONTACT 3 0.0003
720 INJECTION SITE HAEMORRHAGE 21 0.0003
721 ACIDOSIS 2 0.0003
722 INCREASED APPETITE 5 0.0003
723 CONSTIPATION 57 0.0003
724 FEAR 7 0.0003
725 PYREXIA 90 0.0003
726 APHTHOUS ULCER 2 0.0003
727 DEVICE INFORMATION OUTPUT ISSUE 2 0.0003
728 BRONCHITIS 19 0.0003
729 NERVOUS SYSTEM DISORDER 8 0.0003
730 HEART RATE DECREASED 9 0.0003
731 SWOLLEN TONGUE 8 0.0003
732 NASAL CONGESTION 15 0.0003
733 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
734 DYSPHAGIA 24 0.0003
735 ILLNESS 26 0.0003
736 MYOCLONUS 3 0.0003
737 ACCIDENT 3 0.0003
738 MOVEMENT DISORDER 8 0.0002
739 FEELING ABNORMAL 59 0.0002
740 INTENTIONAL DOSE OMISSION 7 0.0002
741 RESPIRATORY DEPRESSION 3 0.0002
742 SPINAL OPERATION 3 0.0002
743 INFLUENZA 27 0.0002
744 ILEUS 3 0.0002
745 VISUAL ACUITY REDUCED 8 0.0002
746 EPISTAXIS 18 0.0002
747 COAGULOPATHY 4 0.0002
748 BRAIN OEDEMA 3 0.0002
749 BLOOD PRESSURE INCREASED 36 0.0002
750 HOSPITALISATION 36 0.0002
751 HIATUS HERNIA 3 0.0002
752 DISEASE RECURRENCE 11 0.0002
753 COMA 11 0.0002
754 SYNCOPE 23 0.0002
755 PSORIASIS 30 0.0002
756 ANHEDONIA 6 0.0002
757 GASTRITIS 6 0.0002
758 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
759 FACIAL PAIN 2 0.0002
760 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
761 THROAT TIGHTNESS 6 0.0002
762 DRUG TOXICITY 3 0.0002
763 PANIC ATTACK 8 0.0002
764 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
765 VISUAL IMPAIRMENT 27 0.0002
766 MUSCLE TWITCHING 5 0.0002
767 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
768 INJECTION SITE MASS 8 0.0002
769 COGNITIVE DISORDER 10 0.0002
770 ABORTION INDUCED 2 0.0002
771 EYE INFLAMMATION 2 0.0002
772 ANGINA PECTORIS 6 0.0002
773 PRURITUS 79 0.0002
774 HOSPICE CARE 2 0.0002
775 SINUS DISORDER 4 0.0002
776 PULMONARY OEDEMA 9 0.0002
777 ABORTION SPONTANEOUS 8 0.0002
778 HALLUCINATION 15 0.0002
779 PRODUCT PHYSICAL ISSUE 4 0.0002
780 ECONOMIC PROBLEM 3 0.0002
781 PRODUCT ADMINISTRATION ERROR 4 0.0002
782 EYELID PTOSIS 2 0.0002
783 DRY THROAT 2 0.0002
784 DRUG RESISTANCE 5 0.0002
785 ECZEMA 10 0.0002
786 COUGH 53 0.0002
787 LOSS OF CONSCIOUSNESS 24 0.0002
788 PRODUCT DOSE OMISSION ISSUE 55 0.0002
789 MENSTRUATION IRREGULAR 5 0.0002
790 DYSARTHRIA 7 0.0002
791 DECREASED ACTIVITY 2 0.0002
792 DEVICE MALFUNCTION 13 0.0002
793 FAECES DISCOLOURED 4 0.0002
794 SWELLING FACE 12 0.0002
795 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
796 GASTROINTESTINAL PAIN 2 0.0002
797 DRUG LEVEL INCREASED 3 0.0002
798 VERTIGO 11 0.0002
799 DRY EYE 9 0.0002
800 TRANSAMINASES INCREASED 4 0.0002
801 RASH MACULO-PAPULAR 4 0.0002
802 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
803 FISTULA 2 0.0002
804 HYPERSOMNIA 5 0.0002
805 SHOCK 4 0.0002
806 HYPOKALAEMIA 8 0.0002
807 OROPHARYNGEAL PAIN 16 0.0002
808 HOT FLUSH 13 0.0002
809 EYELID OEDEMA 2 0.0002
810 LIVER FUNCTION TEST ABNORMAL 5 0.0002
811 CAESAREAN SECTION 2 0.0002
812 SYRINGE ISSUE 3 0.0002
813 NO ADVERSE EVENT 31 0.0002
814 BONE PAIN 10 0.0002
815 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
816 PRODUCT DOSE OMISSION 11 0.0002
817 ISCHAEMIC STROKE 3 0.0002
818 CHOLECYSTITIS 2 0.0002
819 CEREBRAL HAEMORRHAGE 6 0.0002
820 COMPLICATION OF DEVICE REMOVAL 3 0.0002
821 LOCALISED INFECTION 4 0.0002
822 ARTHRITIS 13 0.0002
823 RESTLESS LEGS SYNDROME 3 0.0002
824 PRESYNCOPE 4 0.0002
825 ANAPHYLACTIC REACTION 9 0.0002
826 VAGINAL HAEMORRHAGE 7 0.0002
827 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
828 MENTAL DISORDER 7 0.0002
829 DRUG WITHDRAWAL SYNDROME 14 0.0002
830 PHOTOPHOBIA 3 0.0002
831 BLOOD URINE PRESENT 3 0.0002
832 GASTRIC ULCER 3 0.0002
833 SLEEP APNOEA SYNDROME 3 0.0002
834 INJECTION SITE SWELLING 12 0.0002
835 DEVICE DEPLOYMENT ISSUE 2 0.0002
836 LACTIC ACIDOSIS 5 0.0002
837 DYSPHONIA 9 0.0002
838 SKIN DISCOLOURATION 7 0.0002
839 STAPHYLOCOCCAL INFECTION 5 0.0002
840 BLOOD PRESSURE ABNORMAL 3 0.0002
841 COMPLICATION OF DEVICE INSERTION 3 0.0002
842 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
843 ACUTE KIDNEY INJURY 23 0.0002
844 JAUNDICE 4 0.0001
845 GINGIVAL BLEEDING 2 0.0001
846 RASH ERYTHEMATOUS 7 0.0001
847 PRODUCT PREPARATION ERROR 3 0.0001
848 DEVICE MECHANICAL ISSUE 2 0.0001
849 GASTRIC DISORDER 5 0.0001
850 FEELING COLD 4 0.0001
851 HUNGER 2 0.0001
852 BURNING SENSATION 10 0.0001
853 MOUTH ULCERATION 3 0.0001
854 CARDIOGENIC SHOCK 2 0.0001
855 DEVICE LEAKAGE 6 0.0001
856 PRODUCT PRESCRIBING ISSUE 3 0.0001
857 RESPIRATORY FAILURE 10 0.0001
858 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
859 CHILLS 16 0.0001
860 STEVENS-JOHNSON SYNDROME 3 0.0001
861 PREMATURE BABY 4 0.0001
862 DEVICE FAILURE 2 0.0001
863 INJECTION SITE PAIN 40 0.0001
864 INJECTION SITE RASH 4 0.0001
865 EJECTION FRACTION DECREASED 2 0.0001
866 FLUSHING 13 0.0001
867 PRODUCTIVE COUGH 6 0.0001
868 CYSTITIS 4 0.0001
869 METABOLIC ACIDOSIS 4 0.0001
870 HAEMORRHAGE 13 0.0001
871 HYPOGLYCAEMIA 6 0.0001
872 BLOOD CREATININE INCREASED 8 0.0001
873 BLOOD PRESSURE DECREASED 8 0.0001
874 PNEUMONIA ASPIRATION 3 0.0001
875 SURGERY 7 0.0001
876 HAEMATEMESIS 3 0.0001
877 CARDIOVASCULAR DISORDER 3 0.0001
878 HAEMATURIA 4 0.0001
879 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
880 SKIN ULCER 3 0.0001
881 EMOTIONAL DISTRESS 14 0.0001
882 DIPLOPIA 3 0.0001
883 DEVICE DISLOCATION 5 0.0001
884 DEAFNESS 3 0.0001
885 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
886 DEVICE USE ISSUE 2 0.0001
887 HYPERKALAEMIA 4 0.0001
888 COVID-19 20 0.0001
889 HYPOXIA 4 0.0001
890 DRUG ERUPTION 2 0.0001
891 DEVICE ISSUE 10 0.0001
892 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
893 THROAT IRRITATION 5 0.0001
894 GASTROENTERITIS VIRAL 2 0.0001
895 HYPERGLYCAEMIA 4 0.0001
896 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
897 SKIN LESION 3 0.0001
898 INFLUENZA LIKE ILLNESS 9 0.0001
899 SKIN IRRITATION 5 0.0001
900 HEPATIC STEATOSIS 2 0.0001
901 PAIN IN JAW 3 0.0001
902 COLITIS 4 0.0001
903 DEHYDRATION 14 0.0001
904 HERNIA 2 0.0001
905 DYSSTASIA 3 0.0001
906 HAEMORRHOIDS 2 0.0001
907 ASCITES 3 0.0001
908 ACUTE MYOCARDIAL INFARCTION 3 0.0001
909 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
910 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
911 HAEMATOCRIT DECREASED 2 0.0001
912 CORONARY ARTERY DISEASE 3 0.0001
913 FEEDING DISORDER 2 0.0001
914 DEVICE BREAKAGE 4 0.0001
915 GYNAECOMASTIA 3 0.0001
916 DRUG ABUSE 8 0.0001
917 BONE DENSITY DECREASED 3 0.0001
918 DERMATITIS 2 0.0001
919 BACK PAIN 22 0.0001
920 HYPOTHYROIDISM 3 0.0001
921 BALANCE DISORDER 8 0.0001
922 ERYTHEMA 19 0.0001
923 HAEMATOCHEZIA 5 0.0001
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
925 SKIN DISORDER 3 0.0001
926 NEUTROPENIA 12 0.0001
927 EYE IRRITATION 5 0.0001
928 LYMPHADENOPATHY 3 0.0001
929 ARRHYTHMIA 4 0.0001
930 PULMONARY EMBOLISM 8 0.0001
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
932 ANAEMIA 16 0.0001
933 DIABETIC KETOACIDOSIS 2 0.0001
934 URINARY TRACT INFECTION 14 0.0001
935 EYE SWELLING 3 0.0001
936 UNEVALUABLE EVENT 6 0.0001
937 HAEMOGLOBIN DECREASED 8 0.0001
938 ANAPHYLACTIC SHOCK 2 0.0001
939 RHINORRHOEA 5 0.0001
940 EXPOSURE VIA SKIN CONTACT 2 0.0001
941 DRUG DOSE OMISSION BY DEVICE 6 0.0001
942 INJECTION SITE PRURITUS 5 0.0001
943 INCORRECT DOSE ADMINISTERED 17 0.0001
944 DEATH 64 0.0001
945 DRUG EFFECT DECREASED 4 0.0001
946 EXTRA DOSE ADMINISTERED 3 0.0001
947 BLOOD BILIRUBIN INCREASED 2 0.0001
948 FLATULENCE 4 0.0001
949 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
950 DYSGEUSIA 5 0.0001
951 ACNE 5 0.0001
952 PLATELET COUNT DECREASED 7 0.0001
953 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
954 HEAD INJURY 2 0.0001
955 MULTIPLE SCLEROSIS 3 0.0001
956 THROMBOSIS 5 0.0001
957 DEVICE EXPULSION 4 0.0001
958 EXPIRED PRODUCT ADMINISTERED 2 0.0001
959 EYE PRURITUS 2 0.0001
960 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
961 DRUG EFFECT INCOMPLETE 2 0.0001
962 SEPSIS 6 0.0001
963 HEPATIC FUNCTION ABNORMAL 2 0.0001
964 HYPONATRAEMIA 3 0.0001
965 DYSPNOEA EXERTIONAL 2 0.0001
966 CHRONIC KIDNEY DISEASE 4 0.0001
967 NEUROPATHY PERIPHERAL 5 0.0001
968 DIABETES MELLITUS 4 0.0001
969 CONVULSION 3 0.0001
970 DRY SKIN 7 0.0001
971 INJECTION SITE BRUISING 4 0.0001
972 DRUG DEPENDENCE 8 0.0000
973 DEEP VEIN THROMBOSIS 3 0.0000
974 THROMBOCYTOPENIA 5 0.0000
975 THERAPY INTERRUPTED 3 0.0000
976 BLOOD GLUCOSE DECREASED 2 0.0000
977 CEREBROVASCULAR ACCIDENT 7 0.0000
978 CELLULITIS 2 0.0000
979 RENAL IMPAIRMENT 3 0.0000
980 EYE PAIN 2 0.0000
981 DISEASE PROGRESSION 4 0.0000
982 INJECTION SITE ERYTHEMA 4 0.0000
983 RENAL FAILURE 4 0.0000
984 MYOCARDIAL INFARCTION 4 0.0000
985 CARDIAC DISORDER 2 0.0000
986 CHEST DISCOMFORT 2 0.0000
987 BLOOD GLUCOSE INCREASED 3 0.0000